New Journey Health Technology Group Co.,LTD (SHE:002219)

China · Delayed Price · Currency is CNY

2.100

+0.020 (0.96%)

Sep 30, 2026, 3:04 PM CST

Market Cap	7.23B -2.3%
Revenue (ttm)	2.87B -15.4%
Net Income	30.54M -50.0%
EPS	0.01 -52.1%
Shares Out	3.44B
PE Ratio	225.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,593,795
Open	2.080
Previous Close	2.080
Day's Range	2.060 - 2.110
52-Week Range	1.690 - 2.970
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:002219

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as oncology, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Astragalus and Schisandra tablets, Maiping tablets, Qianlie Antong tablets, Prosta Antong tablets, Gongliuning capsules, cough... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2001

Employees 8,843

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002219

Full Company Profile

Financial Performance

In 2025, SHE:002219's revenue was 3.05 billion, a decrease of -19.64% compared to the previous year's 3.80 billion. Earnings were 30.94 million, a decrease of -73.04%.

Financial Statements